Currently predicting for Thu, 4 Jun 2026

LLY Prediction Chart

LLY Predictions History

Latest community submissions for LLY.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 14, 2026 $1,069.66 -0.70% $1,073.29 V 99.66% 5
Jan 14, 2026 Bullish $1,073.29 X 0
Jan 12, 2026 $1,051.06 -1.18% $1,081.00 X 97.23% 0
Jan 12, 2026 $1,055.75 -0.73% $1,081.00 X 97.66% 0
Jan 12, 2026 Bullish $1,081.00 V 1
Jan 12, 2026 $1,042.19 -2.01% $1,081.00 X 96.41% 0
Jan 12, 2026 Bullish $1,081.00 V 1
Jan 12, 2026 Bullish $1,081.00 V 1
Dec 10, 2025 $993.00 +1.15% $992.94 V 99.99% 10
Dec 10, 2025 $988.75 +0.72% $992.94 V 99.58% 5
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LLY with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ELI LILLY AND COMPANY
Eli Lilly
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE